IDH2 Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation (NCT04281498) | John Mascarenhas | 2021-01-14 |
| BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations (NCT03914742) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-02-16 |
Track IDH2 Mutation automatically
Every clearance here is in the API, with alerts when new ones post.